BioAegis Therapeutics and EastHORN Expand Phase 2 COVID-19 Clinical Trial within Spain and into Romania
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
August 11, 2020 ___________________________________________...